Rang	Name	Position
1	Dr. Taylor H. Schreiber M.D., Ph.D.	Co-Founder, CEO & Director
2	Mr. Andrew R. Neill M.B.A.	Chief Financial Officer
3	Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.	Chief Medical Officer
4	Mr. Brad Huckabee	Vice President of Accounting & SEC reporting
5	Dr. Abhinav A. Shukla Ph.D.	Chief Technical Officer
6	Mr. Suresh de Silva Ph.D.	Chief Scientific Officer
7	Dr. Stephen Stout J.D., Ph.D.	General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
8	Ms. Casi DeYoung	Chief Business Officer
9	Dr. Thomas Lampkin Pharm.D.	Senior Vice President of Regulatory Affairs
10	Ms. Kelli Collin M.B.A., M.S.	Senior Vice President of Quality

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	T. Rowe Price Investment Management,Inc.	9,83%	61,17 Mio. USD
2	Adage Capital Partners Gp LLC	8,09%	50,36 Mio. USD
3	Redmile Group, LLC	6,87%	42,73 Mio. USD
4	Orbimed Advisors LLC	6,28%	39,10 Mio. USD
5	Prosight Management, LP	5,94%	36,94 Mio. USD
6	NEXTBio Capital Management LP	3,71%	23,11 Mio. USD
7	Deep Track Capital, LP	3,69%	22,98 Mio. USD
8	Vanguard Capital Management, LLC	2,27%	14,12 Mio. USD
9	Pinnacle Associates Inc	1,86%	11,60 Mio. USD
10	T. Rowe Price Associates, Inc.	1,78%	11,05 Mio. USD
11	Wellington Management Company LLP	1,76%	10,96 Mio. USD
12	Clark Estates Inc	1,43%	8,87 Mio. USD
13	Aberdeen Group PLC	1,40%	8,72 Mio. USD
14	Point72 Asset Management, L.P.	1,03%	6,39 Mio. USD
15	Ameriprise Financial Inc	0,90%	5,62 Mio. USD
16	683 Capital Management LLC	0,80%	4,96 Mio. USD
17	Susquehanna International Group, LLP	0,71%	4,44 Mio. USD
18	Geode Capital Management, LLC	0,64%	4,00 Mio. USD
19	Renaissance Technologies Corp	0,60%	3,75 Mio. USD
20	Marshall Wace Asset Management Ltd	0,58%	3,61 Mio. USD